News

Survivors of the disease have been found to be at an increased risk of blood clots or strokes due to a prolonged immune response caused by the virus.

More respondents with an infection reported daily burnout than those who did not have one.

People who received their vaccine were also significantly less likely to require hospitalization.

Long-acting injectables for latent and active tuberculous (TB) might be a treatment option in the future and could open up the door to possibly bundling HIV and TB care together.

To mark World TB Day, a pair of experts break down the currently defined regimens for latent and active tuberculosis—and what may still come.

A statement hours after the company reported promising interim phase 3 data stated the Data Safety and Monitoring Board believes they included outdated data “which may have provided an incomplete view of the efficacy data.”

Filmmaker Bill Mudge has released his new documentary, Beating Superbugs: Can We Win? It looks at emerging technologies designed to develop new therapies to combat antibiotic resistance (ABR).

Levels of interferon gene activity were much lower in those with the missense mutation.

Regeneron announces results from Phase 3 trial of its monoclonal antibody treatment.

Facilities in Connecticut had an outbreak prior to vaccinating their residents, which in turn controlled the spread effectively.

Reproduction number should govern allocation of the shot, researchers say.

New polls shows confidence in AstraZeneca vaccine plummets in Europe.

The small country's emphasis on accessible testing provided more up-to-date tracking, and opportunity for research into reinfection risk.

After a year of setbacks, AZD1222 has been associated with 100% prevention of severe COVID-19 in US trial participants. Could emergency authorization come soon?

An interview on perspectives learned from a nationwide PCR test database assessment.

The Infectious Diseases Society of America (IDSA) discusses some of the new treatments show measurable impact on severe disease and death.

8% of ischemic stroke patients had atrial fibrillation, while 9% of those without stroke also had atrial fibrillation.

COVID-19 vaccine development demanded an adults-first approach. A year in, children are being invited to participate in trials in hopes of getting the pediatric population vaccinated later this year.

Machine learning is a promising and potentially powerful technique for detection and prognosis of disease.

Regardless of symptom status, the rate of participants positive for pan-immunoglobulins with neutralizing antibodies at baseline remained stable throughout 2020.

Approaches that measure the indirect effect of the virus on the host may offer complementary solutions in clinical or mass testing.

New drugs likely won’t meet resistance challenges ahead, authors say.

Getting kids back in classrooms is crucial, and it can be done with planning and forethought.

The US was poised in many ways to handle a public health emergency, but the attempt was largely a failure. What happened and how can we push forward?

No causative link has been established between the shot and blood clots or severe bleeding.

Ultrasound is known to cause the breaking up of kidney stones and opening the lipid shell of liposome for drug delivery.

Recruitment for a phase 2 trial of a novel antibiotic against Clostridium difficile (C diff) is proceeding after phase 1 demonstrated safety and tolerability.

The new findings support increased protection from reinfection up to 6 months after first testing positive, though older patients are at greater risk of reinfection.